Literature DB >> 28010994

Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial.

Suzanne Hagen1, Cathryn Glazener2, Doreen McClurg3, Christine Macarthur4, Andrew Elders3, Peter Herbison5, Don Wilson6, Philip Toozs-Hobson7, Christine Hemming8, Jean Hay-Smith9, Marissa Collins10, Sylvia Dickson11, Janet Logan3.   

Abstract

BACKGROUND: Pelvic floor muscle training can reduce prolapse severity and symptoms in women seeking treatment. We aimed to assess whether this intervention could also be effective in secondary prevention of prolapse and the need for future treatment.
METHODS: We did this multicentre, parallel-group, randomised controlled trial at three centres in New Zealand and the UK. Women from a longitudinal study of pelvic floor function after childbirth were potentially eligible for inclusion. Women of any age who had stage 1-3 prolapse, but had not sought treatment, were randomly assigned (1:1), via remote computer allocation, to receive either one-to-one pelvic floor muscle training (five physiotherapy appointments over 16 weeks, and annual review) plus Pilates-based pelvic floor muscle training classes and a DVD for home use (intervention group), or a prolapse lifestyle advice leaflet (control group). Randomisation was minimised by centre, parity (three or less vs more than three deliveries), prolapse stage (above the hymen vs at or beyond the hymen), and delivery method (any vaginal vs all caesarean sections). Women and intervention physiotherapists could not be masked to group allocation, but allocation was masked from data entry researchers and from the trial statistician until after database lock. The primary outcome was self-reported prolapse symptoms (Pelvic Organ Prolapse Symptom Score [POP-SS]) at 2 years. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01171846.
FINDINGS: Between Dec 21, 2008, and Feb 24, 2010, in New Zealand, and Oct 27, 2010, and Sept 5, 2011, in the UK, we randomly assigned 414 women to the intervention group (n=207) or the control group (n=207). One participant in each group was excluded after randomisation, leaving 412 women for analysis. At baseline, 399 (97%) women had prolapse above or at the level of the hymen. The mean POP-SS score at 2 years was 3·2 (SD 3·4) in the intervention group versus 4·2 (SD 4·4) in the control group (adjusted mean difference -1·01, 95% CI -1·70 to -0·33; p=0·004). The mean symptom score stayed similar across time points in the control group, but decreased in the intervention group. Three adverse events were reported, all of which were in the intervention group (one women had a fall, one woman had a pain in her tail bone, and one woman had chest pain and shortness of breath).
INTERPRETATION: Our study shows that pelvic floor muscle training leads to a small, but probably important, reduction in prolapse symptoms. This finding will be important for women and caregivers considering preventive strategies. FUNDING: Wellbeing of Women charity, the New Zealand Continence Association, and the Dean's Bequest Fund of Dunedin School of Medicine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28010994     DOI: 10.1016/S0140-6736(16)32109-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Narrative review of pelvic floor muscle training for childbearing women-why, when, what, and how.

Authors:  Stephanie J Woodley; E Jean C Hay-Smith
Journal:  Int Urogynecol J       Date:  2021-05-05       Impact factor: 2.894

Review 2.  A review of the impact of pregnancy and childbirth on pelvic floor function as assessed by objective measurement techniques.

Authors:  Hans Van Geelen; Donald Ostergard; Peter Sand
Journal:  Int Urogynecol J       Date:  2018-01-13       Impact factor: 2.894

Review 3.  [Statin intolerance and statin-associated muscular pain].

Authors:  Paulina Elena Stürzebecher; Friederike Schumann; Ursula Kassner; Ulrich Laufs
Journal:  Herz       Date:  2022-04-22       Impact factor: 1.740

4.  Effects of Adding Ultrasound Biofeedback to Individualized Pelvic Floor Muscle Training on Extensibility of the Pelvic Floor Muscle and Anterior Pelvic Organ Prolapse in Postmenopausal Women.

Authors:  Xiaoning Gu; Min Yang; Fang Liu; Dongmei Liu; Fuwen Shi
Journal:  Contrast Media Mol Imaging       Date:  2022-06-23       Impact factor: 3.009

Review 5.  The effect of pelvic floor muscle training for women with pelvic organ prolapse: a meta-analysis.

Authors:  Ting Wang; Zhengfang Wen; Meng Li
Journal:  Int Urogynecol J       Date:  2022-03-21       Impact factor: 1.932

6.  What do female university students know about pelvic floor disorders? A cross-sectional survey.

Authors:  Marta Bailón Queiruga; Aina Delgado-Morell; Marta Peró Garcia; Sandra Coll Girona; Ignasi Gich Saladich; Oriol Porta Roda
Journal:  Int Urogynecol J       Date:  2021-05-15       Impact factor: 2.894

7.  The Association Between Pelvic Floor Muscle Force and General Strength and Fitness in Postpartum Women.

Authors:  Whitney Moss; Janet M Shaw; Meng Yang; Xiaoming Sheng; Robert Hitchcock; Stefan Niederauer; Diane Packer; Ingrid E Nygaard
Journal:  Female Pelvic Med Reconstr Surg       Date:  2020-06       Impact factor: 1.913

8.  Is Bariatric Surgery a Prophylaxis for Pelvic Floor Disorders?

Authors:  Andrzej Pomian; Wojciech Majkusiak; Wojciech Lisik; Paweł Tomasik; Edyta Horosz; Aneta Zwierzchowska; Jacek Kociszewski; Ewa Barcz
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

9.  Women's experiences of managing digitation: do we ask enough in primary care?

Authors:  Sharon Eustice; Ruth Endacott; Jenny Morris; Rohit Shankar; Bridie Kent
Journal:  JRSM Open       Date:  2018-08-06

10.  What Influences Women to Adhere to Pelvic Floor Exercises after Physiotherapy Treatment? A Qualitative Study for Individualized Pelvic Health Care.

Authors:  Beatriz Navarro-Brazález; Fernando Vergara-Pérez; Virginia Prieto-Gómez; Beatriz Sánchez-Sánchez; María José Yuste-Sánchez; María Torres-Lacomba
Journal:  J Pers Med       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.